Symbol="VACC"
AssetType="Common Stock"
Name="Vaccitech PLC ADR"
Description="Vaccitech plc, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new T-cell vaccines and immunotherapies for the treatment and prevention of infectious diseases and cancers. The company is headquartered in Oxford, United Kingdom."
CIK="1828185"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="THE SCHRODINGER BUILDING, HEATLEY ROAD, THE OXFORD SCIENCE PARK, OXFORD, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="76087000"
EBITDA="-62911000"
PERatio="None"
PEGRatio="None"
BookValue="5.64"
DividendPerShare="0"
DividendYield="0"
EPS="-1.48"
RevenuePerShareTTM="0.356"
ProfitMargin="0"
OperatingMarginTTM="-4.812"
ReturnOnAssetsTTM="-0.152"
ReturnOnEquityTTM="-0.233"
RevenueTTM="13424000"
GrossProfitTTM="44703000"
DilutedEPSTTM="-1.48"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.98"
AnalystTargetPrice="12"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.311"
PriceToBookRatio="0.359"
EVToRevenue="1.506"
EVToEBITDA="-9.07"
Beta="0.136"
num_52WeekHigh="4.3"
num_52WeekLow="1.94"
num_50DayMovingAverage="2.194"
num_200DayMovingAverage="2.452"
SharesOutstanding="38525000"
DividendDate="None"
ExDividendDate="None"
symbol="VACC"
open="1.95"
high="2.03"
low="1.95"
price="2.01"
volume="6627.00"
latest_trading_day="2023-08-30"
previous_close="2.00"
change="0.01"
change_percent="0.5000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="95"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="5"
Volume_recent_avg="17314"
Change_recent_avg="-0.02"
Delta_recent_avg="0.11"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.88"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="5"
Aroon_momentum_negative="95"
image_negative_thumbnail_id_1="1130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0163.jpeg"
image_negative_thumbnail_id_2="519"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="701"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_positive_thumbnail_id_2="696"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0012.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
